2G: Immune Engineering SIG 1
Time: 2:45 PM to 4:15 PM
Description
Over the past decade the focus of many bioengineers and clinicians has been shifting towards "immune engineering" approaches that include but are not limited to engineered biomaterials for vaccines, immunotherapy (immune-modulation), cell and gene therapy, immune microenvironment engineering, and systems immunology. These research areas embrace a comprehensive list of translational immunology-associated problems including chronic infections, autoimmune diseases, aggressive cancers, allergies, etc. The purpose of the Immune Engineering SIG is to bring together emerging ideas and provide a venue for professional interaction to a large number of academic and industrial research groups and scientists working in these areas.
Moderator:
Xiao Huang, Drexel Univeristy
Objectives
2:45 PM. 75. Implantable biomaterial microporous scaffolds predict food allergy severity as a surrogate of immune dynamics in the gastrointestinal tract.Laila Rad, MSE1, Russell Urie, PhD1, Michael Saunders, BS1, Jessica O'Konek, PhD1, Lonnie Shea1 1University of Michigan
3:15 PM. 76. Targetless Immunotherapy Rescues Mice From LPS-Induced Septic Shock.Helena Freire Haddad1, Pablo Cordero Alvarado1, Maria Kulapurathazhe1, Emily Roe1, Vinicius Xie Fu1, Joel Collier, PhD1 1Duke University
3:30 PM. 77. Immunomodulatory cytokine factories prevent foreign body response against encapsulated islets and delay the onset of diabetes..Boram Kim1, Amanda Nash2, Yuen San Chan3, Samantha Fleury4, Shravani Deo5, Danna Murungi4, Courtney Hodges3, Omid Veiseh4, Dilrasbonu Vohidova4 1MIT, 2MaKinsey, 3Baylor College of Medicine, 4Rice University, 5N/A
3:45 PM. 78. Placental Mimicry Cell Therapy Delays Bystander Cell Rejection in Xenotransplant Model.Shivani Hiremath, MS1, Chishiba Chilimba, MS1, JESSICA WEAVER, PhD1 1Arizona State University
4:00 PM. 79. Localized Delivery of Indoleamine-2,3-Dioxygenase (IDO) - Galectin 3 Fused Enzyme Using Decellularized Sciatic Nerve for Injured Spinal Cord Immune Modulation and Regeneration.Allison Campbell, B.S.1, Gopal Agarwal, PhD1, Arun Wanchoo, PhD1, Prodip Bose, PhD1, Gregory Hudalla, PhD1, Benjamin Keselowsky, PhD1, Christine Schmidt, PhD1 1University of Florida
3:00 PM. 80. Nanoimmunomaterials from the Johns Hopkins Translational ImmunoEngineering Center Enable Immune Cell Specific Targeting.Jordan Green, Ph.D.1 1Johns Hopkins University